Indications
Ritsight is a class IIb medical device for the indication of use to protect the inner ocular structures from the excessive exposure of UV-A light radiation during the corneal cross-linking procedure for the treatment of keratoconus, iatrogenic corneal ectasia, bullous keratopathy and keratitis.
The medical device can be applied on the cornea manually in either epi-off or epi-on corneal cross-linking protocols and via controlled corneal iontophoresis.
Technical Features
- 3-years expire date. Storage at room temperature (4° - 25° C)
- Unique formulation for EpiOFF and EpiON CXL protocols
- Packaging with Data Matrix Code for UV-A devices with integrated digital traceability
Mode of use
RitSight can be used either for epi-off (i.e., with epithelial removal) or epi-on (or transepithelial) corneal cross-linking protocols.
RitSight is instilled directly onto the cornea. A drop can be applied 3 times per minute onto to the cornea for at least 10 minutes before UV-A irradiation.
The UV-A irradiation must follow only after adequate imbibition of the cornea with RitSight. The UV-A irradiation power or the emitted UV-A energy dose must not exceed 40 mW/cm2 or 10 J/cm2 respectively. It is recommended to use a theranostic UV medical device estimating the corneal riboflavin concentration and the emitted UV energy dose.
Protocollo CXL EpiOFF:
decreases the soaking
time improving
treatment safety and efficacy
EpiON CXL protocol:
improves tratment efficacy thanks to greater stromal penetration through the intact epithelium. It is specifically designed for corneal iontophoresis delivery
Thin keratoconus corneas:
Indicated for treating very thin corneas (370 µm)
